Healthcare
NASDAQ companies operating within the Healthcare sector, ranked by market capitalization.
| LXEO | NASDAQ | Lexeo Therapeutics, Inc. Common Stock | $2.70 | -3.57% | 1.2M | $221.64M |
| PALI | NASDAQ | Palisade Bio, Inc. | $1.23 | -7.52% | 1.7M | $214.35M |
| PRLD | NASDAQ | Prelude Therapeutics Incorporated | $3.70 | +1.93% | 237K | $214.16M |
| SPOK | NASDAQ | Spok Holdings, Inc. | $10.21 | -0.87% | 193K | $213.26M |
| IKT | NASDAQ | Inhibikase Therapeutics, Inc. | $1.52 | -4.40% | 860K | $212.09M |
| BBOT | NASDAQ | BridgeBio Oncology Therapeutics Inc. | $2.64 | -0.75% | 483K | $211.66M |
| GALT | NASDAQ | Galectin Therapeutics Inc. | $3.19 | -0.31% | 164K | $210.08M |
| RXST | NASDAQ | RxSight, Inc. | $4.93 | -1.79% | 451K | $205.05M |
| ALEC | NASDAQ | Alector, Inc. | $1.83 | -1.29% | 2.7M | $204.33M |
| SRZN | NASDAQ | Surrozen, Inc. | $27.28 | +7.06% | 511K | $203.98M |
| PROF | NASDAQ | Profound Medical Corp. | $5.55 | -0.18% | 142K | $202.76M |
| CTY | NASDAQ | City Therapeutics Inc. | $20.79 | +0.10% | 136K | $202.12M |
| CAMP | NASDAQ | CAMP4 Therapeutics Corporation | $3.21 | -2.73% | 60K | $201.44M |
| PDEX | NASDAQ | Pro-Dex, Inc. | $60.66 | -2.51% | 52K | $196.13M |
| NAGE | NASDAQ | Niagen Bioscience Inc | $2.44 | +0.41% | 406K | $193.07M |
| IVA | NASDAQ | Inventiva S.A. | $3.66 | -1.35% | 3.3M | $190.25M |
| RNAC | NASDAQ | Cartesian Therapeutics, Inc. | $6.28 | +1.62% | 106K | $190M |
| INGN | NASDAQ | Inogen, Inc. | $7.08 | -0.28% | 192K | $187.89M |
| BIOA | NASDAQ | BioAge Labs Inc. | $4.99 | -2.16% | 539K | $187.87M |
| YARW | NASDAQ | Yarrow Bioscience Inc | $20.00 | +3.79% | 162K | $186.09M |
| TRDA | NASDAQ | Entrada Therapeutics, Inc. | $4.75 | +7.71% | 617K | $184.95M |
| XGN | NASDAQ | Exagen Inc. | $7.47 | +2.75% | 191K | $180.96M |
| ELDN | NASDAQ | Eledon Pharmaceuticals, Inc. | $2.21 | -3.91% | 653K | $179.59M |
| WHWK | NASDAQ | Whitehawk Therapeutics Inc | $3.14 | -2.18% | 236K | $179.01M |
| AKBA | NASDAQ | Akebia Therapeutics, Inc. | $0.6438 | +13.56% | 11.5M | $178.4M |
| CGEN | NASDAQ | Compugen Ltd. | $1.88 | -3.35% | 334K | $177.61M |
| ETRA | NASDAQ | Electra Therapeutics Inc. | $8.37 | -3.90% | 159K | $177.55M |
| KRRO | NASDAQ | Korro Bio, Inc. | $12.02 | +0.33% | 180K | $177M |
| DTIL | NASDAQ | Precision BioSciences, Inc. | $6.41 | -3.46% | 267K | $176.93M |
| PRQR | NASDAQ | ProQR Therapeutics N.V. | $1.24 | -3.88% | 938K | $174.99M |
| IVVD | NASDAQ | Invivyd, Inc. | $0.5892 | -3.95% | 2.8M | $173.67M |
| BDSX | NASDAQ | Biodesix, Inc. | $21.26 | +0.38% | 61K | $173.06M |
| PEPG | NASDAQ | PepGen Inc. | $2.49 | -1.19% | 907K | $172.23M |
| OPRX | NASDAQ | OptimizeRx Corp. | $9.07 | -0.87% | 140K | $170.84M |
| STIM | NASDAQ | Neuronetics, Inc. | $2.24 | +6.16% | 1.1M | $170.68M |
| ORMP | NASDAQ | Oramed Pharmaceuticals Inc. | $4.08 | -1.21% | 109K | $169.72M |
| SION | NASDAQ | Sionna Therapeutics, Inc. | $3.69 | +2.50% | 614K | $166.6M |
| ABOS | NASDAQ | Acumen Pharmaceuticals, Inc. | $2.27 | +14.65% | 1.6M | $164.16M |
| NNNN | NASDAQ | Anbio Biotechnology Class A Ordinary Shares | $3.70 | -2.89% | 38K | $162.4M |
| FOCL | NASDAQ | EDAP TMS S.A. American Depositary Shares | $4.23 | +1.44% | 7K | $158.55M |
| IPHA | NASDAQ | Innate Pharma S.A. | $1.46 | -2.67% | 22K | $157.81M |
| ALXO | NASDAQ | ALX Oncology Holdings Inc. | $1.13 | -3.42% | 1M | $156.25M |
| CHRS | NASDAQ | Coherus Oncology, Inc. | $1.01 | -0.50% | 687K | $156.05M |
| MXCT | NASDAQ | MaxCyte, Inc. | $1.51 | +7.86% | 1.1M | $155.84M |
| MDWD | NASDAQ | MediWound Ltd. | $12.07 | +0.54% | 84K | $155.76M |
| APLMW | NASDAQ | Apollomics, Inc. | $0.0104 | -7.13% | 2K | $153.73M |
| NGEN | NASDAQ | NervGen Pharma Corp. Common stock | $1.42 | -0.70% | 259K | $152.68M |
| UPB | NASDAQ | Upstream Bio, Inc. | $2.75 | +0.36% | 984K | $150.62M |
| KRSA | NASDAQ | Korsana Biosciences, Inc. | $32.09 | +2.49% | 230K | $150.22M |
| ZNTL | NASDAQ | Zentalis Pharmaceuticals, Inc. | $2.07 | -6.33% | 1M | $147.36M |
50 Healthcare Companies
Review companies currently returned for the Healthcare screen, with price, performance, volume and market-cap context.
How This Sector Screen Works
Results are loaded from current company data and can be narrowed by exchange or company search without changing the canonical sector page.
About the Healthcare Sector
The Healthcare classification groups companies with related business activities so investors can compare peers within a common market segment.
Related Sector Screens
Return to the screener directory to compare this sector with daily movers and the other industry groups covered by Cashu Finance.